Data / Form D filings / LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXTE BIOTECHNOLOGY HOLDINGS, INC.: Form D filings
LIXTE BIOTECHNOLOGY HOLDINGS, INC., a biotechnology company in Pasadena, CA, filed 4 Form D notices with the SEC between 2009 and 2023. The latest, on August 1, 2023, reports $3.5 million sold of a $3.5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 680 East Colorado Boulevard, Suite 180, Pasadena, CA, 11733
- Phone
- (631) 830-7092
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1335105
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | New notice | $3,500,000 | $3,500,000 | 1 | Jul 20, 2023 | sec.gov | |
| Dec 12, 2018 | New notice | $4,500,000 | $4,500,000 | 15 | Nov 30, 2018 | sec.gov | |
| Jan 27, 2010 | New notice | $1,787,500 | $1,787,500 | 14 | Jan 20, 2010 | sec.gov | |
| Apr 13, 2009 | Amendment | $2,000,000 | $710,000 | $1,290,000 | 28 | Feb 10, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Bas van der Baan | Director | |
| Yun Yen | Director | |
| James Miser | Executive Officer | |
| Robert Weingarten | Executive Officer | |
| Regina Brown | Director | |
| John Kovach | Executive Officer, Director | |
| Rene Bernards | Director | |
| Eric Forman | Executive Officer | |
| Stephen Forman | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jul 31, 2023 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.